Thank you!
Someone from our team will get back to you within one day.
Life sciences organizations are increasingly aware of the powerful role drivers of health (DOH) play in whole-person care. However, it’s often a challenge for life sciences organizations to identify DOH needs for the communities they serve and to successfully factor them into research and development efforts. Clinical trial diversity, in particular, has remained both a pressing challenge and a key priority.
We interviewed industry expert Dr. Rodrigo Burgos, Clinical Assistant Professor and HIV PGY-2 Residency Co-Director at the University of Illinois Chicago, to share his thoughts on the evolving matter of clinical trial diversity. As an HIV pharmacotherapy specialist and pharmacy residency director, Dr. Burgos is committed to expanding opportunities to support pharmacists who serve marginalized communities.
Read the Q&A report to learn more.
Learn More
Navigating Medicaid Transformation: Lessons Learned for CBOs
December 12, 2024
Integrating Social Care Delivery into the Opioid Epidemic Response
November 12, 2024
In Disaster Relief, People Are More Than Just Data Points
October 8, 2024Request a Demo
Interested in learning more about how community-based organizations are addressing social determinants of health or how to bring Unite Us to your community? Fill out this form and we’ll be in touch.